Search

everythinglearnresearchcommunity

for

Search:↓

Combining scalp reduction and hair transplants improves coverage and appearance for male baldness.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Minoxidil can slow hair loss and promote regrowth but won't fully restore hair.

Surgery successfully treated a hidden ovarian tumor causing hair loss and excess hair growth in a postmenopausal woman.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Sunlight worsens hair loss; protect scalp.

Mast cells might contribute to hair loss by causing skin thickening.

CE-PTG is a better method for analyzing hair growth in androgenetic alopecia.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

UV light does not significantly affect minoxidil's ability to treat male pattern baldness.

Balding and low testosterone increase risk of urinary stones.

Surgical hair restoration has improved since 1959, with new techniques like minigrafts, micrografts, and scalp reductions creating more natural hairlines and reducing bald skin, despite some risks and potential for scarring.

New biological pathways and potential treatment targets for male pattern baldness were identified.

Scalp tissue micrografts can effectively treat hair loss by increasing hair density and thickness.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Higher androgen levels do not cause baldness in men.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The document concludes that using autologous follicular unit implantation is a successful method to correct hairline deformities after facial rejuvenation.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

Contact dermatitis may speed up hair loss in some cases.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

Finasteride improves hair growth and satisfaction in men with male pattern baldness but may cause sexual side effects.